Synthesis, molecular structures, and chemistry of some new palladium(II) and platinum(II) complexes with pentafluorophenyl ligands

A series of palladium(II) and platinum(II) complexes possessing pentafluorophenyl ligands of the general formula [M(L-L)(C6F5)Cl][space](M = Pd 3; L-L=tmeda (N,N,N',N',-tetramethylethylenediamine) a; 1,2-bis(2,6-dimethylphenylimino)ethane) b; dmpe (1,2-bis(dimethylphosphino)ethane) c; dcpe (1,2-bis(dicyclohexylphosphino)ethane) d; Pt ; L-L=tmeda a; 1,2-bis[3,5-bis(trifluoromethyl)phenylimino]-1,2-dimethylethane b; dmpe c; dcpe d) were readily synthesized from the dimer [M(C6F5)(tht)(mu-Cl)2] (M=Pd 1b, Pt 2b; tht=tetrahydrothiophene) and the corresponding bidentate ligand. In the case of palladium, the corresponding iodo analogues (6a-c) were readily synthesized in a one-pot reaction from [Pd2(dba)3], iodopentafluorobenzene, and the appropriate ligand. The platinum complexes 4c-d were then converted to the water complexes [Pt(L-L)(C6F5)(OH2)]OTf (L-L =dmpe 7a; dcpe 7b)via reaction with AgOTf in the presence of water. Attempts to convert the palladium complexes 3c-d to the corresponding water complexes resulted in the disproportionation of the intermediate water complex to form [Pd(L-L)(C6F5)2] (L-L=dmpe 8) or [Pd(L-L)2][OTf]2(L-L=dcpe 9). Upon standing in solution for prolonged periods, complex 7a undergoes an identical disproportionation reaction to the Pd analogues to form [Pt(L-L)(C6F5)2] (L-L=dmpe 10). Complexes 4c and 4d were converted to the corresponding hydrides (11b-c, respectively) using two different hydride sources: 11a was formed by the reaction of with NaBH4 in refluxing THF, while 11b was synthesized in near quantitative yield using [Cp2ZrH2] in refluxing THF. Attempts to synthesize eta2-tetrafluorobenzyne complexes [Pt(L-L)(C6F4)] (L-L=dmpe, dcpe) from reaction of 11a-b with butyllithium were unsuccessful. The molecular structures of 3a,4a, 4c, 4d, 6b, 7a, 8, 11b and have been determined by X-ray crystallographic studies, and are discussed.     

Synthesis, characterization, DNA binding and cytotoxic studies of platinum(II) and palladium(II) complexes of the 2,2'-bipyridine and an anion of 1,1-cyclobutanedicarboxylic acid.

Two neutral complexes of formula [M(bpy)(cbdca)] [where M is palladium(II) (Pd(II)) or platinum(II) (Pt(II)), bpy is 2,2'-bipyridine and cbdca is anion of 1,1-cyclobutanedicarboxylic acid] have been synthesized. These water soluble complexes have been characterized by chemical analysis and conductivity measurements as well as 1H-NMR, ultraviolet-visible and infrared spectroscopy. In these complexes the ligand cbdca coordinates to Pt(II) or Pd(II) as bidentate with two oxygen atoms. They are nonelectrolyte in conductivity water. These complexes inhibit the growth of P388 lymphocytic leukemia cells and their targets are DNA. They invariably show ID50 values less than cisplatin. [Pt(bpy)(cbdca)] and [Pd(bpy)(cbdca)] have been interacted with calf thymus DNA and bind to DNA through coordinate covalent bond. In addition, the influence of binding of these complexes on the intensity of EtBr-DNA have been studied. They bind to DNA via a nonintercalating mode.     

Palladium(II) and platinum(II) organometallic complexes with the model nucleobase anions of thymine, uracil, and cytosine: antitumor activity and interactions with DNA of the platinum compounds

Pd(II) and Pt(II) complexes with the anions of the model nucleobases 1-methylthymine (1-MethyH), 1-methyluracil (1-MeuraH), and 1-methylcytosine (1-MecytH) of the types [Pd(dmba)(mu-L)]2 [dmba = N,C-chelating 2-((dimethylamino)methyl)phenyl; L = 1-Methy, 1-Meura or 1-Mecyt] and [M(dmba)(L)(L')] [L = 1-Methy or 1-Meura; L' = PPh(3) (M = Pd or Pt), DMSO (M = Pt)] have been obtained. Palladium complexes of the types [Pd(C6F5)(N-N)(L)] [L = 1-Methy or 1-Meura; N-N = N,N,N',N'-tetramethylethylenediamine (tmeda), 2,2'-bipyridine (bpy), or 4,4'-dimethyl-2,2'-bipyridine (Me2bpy)] and [NBu4][Pd(C6F5)(1-Methy)2(H2O)] have also been prepared. The crystal structures of [Pd(dmba)(mu-1-Methy)]2, [Pd(dmba)(mu-1-Mecyt)]2.2CHCl3, [Pd(dmba)(1-Methy)(PPh3)].3CHCl3, [Pt(dmba)(1-Methy)(PPh3)], [Pd(tmeda)(C6F5)(1-Methy)], and [NBu4][Pd(C6F5)(1-Methy)2(H2O)].H2O have been established by X-ray diffraction. The DNA adduct formation of the new platinum complexes synthesized was followed by circular dichroism and electrophoretic mobility. Atomic force microscopy images of the modifications caused by the platinum complexes on plasmid DNA pBR322 were also obtained. Values of IC50 were also calculated for the new platinum complexes against the tumor cell line HL-60. All the new platinum complexes were more active than cisplatin (up to 20-fold in some cases).     

Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds

Palladium and platinum complexes with HmtpO (where HmtpO=4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine, an analogue of the natural occurring nucleobase hypoxanthine) of the types [M(dmba)(PPh3)(HmtpO)]ClO4[dmba=N,C-chelating 2-(dimethylaminomethyl)phenyl; M=Pd or Pt], [Pd(N-N)(C6F5)(HmtpO)]ClO4[N-N=2,2'-bipyridine (bpy), 4,4'-dimethyl-2,2'-bipyridine (Me2bpy), or N, N, N', N'-tetramethylethylenediamine (tmeda)] and cis-[M(C6F5)2(HmtpO)2] (M=Pd or Pt) (head-to-head atropisomer in the solid state) have been obtained. Pd(II) and Pt(II) complexes with the anion of HmtpO of the types [Pd(tmeda)(C6F5)(mtpO)], [Pd(dmba)(micro-mtpO)] 2, and [NBu4]2[M(C6F5)2(micro-mtpO)]2(M=Pd or Pt) have been prepared starting from the corresponding hydroxometal complexes. Complexes containing simultaneously both the neutral HmtpO ligand and the anionic mtpO of the type [NBu4][M(C6F5)2(HmtpO)(mtpO)] (M=Pd or Pt) have been also obtained. In these mtpO-HmtpO metal complexes, for the first time, prototropic exchange is observed between the two heterocyclic ligands. The crystal structures of [Pd(dmba)(PPh 3)(HmtpO)]+, cis-[Pt(C6F5)2(HmtpO)2].acetone, [Pd(C6F5)(tmeda)(mtpO)].2H2O, [Pd(dmba)(micro-mtpO)]2, [NBu4]2[Pd(C6F5)2(micro-mtpO)]2.CH2Cl2.toluene, [NBu4]2[Pt(C6F5)2(micro-mtpO)](2).0.5(toluene), and [NBu4][Pt(C6F5)2(mtpO)(HmtpO)] have been established by X-ray diffraction. Values of IC50 were calculated for the new platinum complexes cis-[Pt(C6F5)2(HmtpO)2] and [Pt(dmba)(PPh3)(HmtpO)]ClO4 against a panel of human tumor cell lines representative of ovarian (A2780 and A2780 cisR), lung (NCI-H460), and breast cancers (T47D). At 48 h incubation time, both complexes were about 8-fold more active than cisplatin in T47D and show very low resistance factors against an A2780 cell line, which has acquired resistance to cisplatin. The DNA adduct formation of cis-[Pt(C6F5)2(HmtpO)2] and [Pt(dmba)(PPh3)(HmtpO)]ClO4 was followed by circular dichroism and electrophoretic mobility. Atomic force microscopy images of the modifications caused by these platinum complexes on plasmid DNA pB R322 were also obtained.     

Synthesis, structural characterization, and photophysical properties of palladium and platinum(II) complexes containing 7,8-benzoquinolinate and various phosphine ligands

A series of mononuclear cyclometalated benzo[h]quinolinate platinum and palladium(II) complexes with phosphine ligands, namely, [M(bzq)ClL] (L=PPh2H, Pt 1, Pd 2; PPh2CCPh, Pt 3, Pd 4), [Pt(bzq)(PPh2H)(PPh2CCPh)]ClO4 5, [Pt(bzq)(PPh2C(Ph)=C(H)PPh2)]ClO4 6, and [Pt(bzq)(CCPh)(PPh2CCPh)] (7a, 7b), were synthesized. The X-ray crystal structures of 1, 6.CH3COCH3.1/2CH3(CH2)4CH3, and 7b.CH3COCH3 have been determined. In 1, the metalated carbon atom and the P atom are mutually cis, whereas in 7b they are trans located. For complex 6, C and N are crystallographically indistinguishable. Reaction of [Pt(bzq)(mu-Cl)]2 with PPh2H and excess of NEt3 leads to the phosphide-bridge platinum dimer [Pt(bzq)(mu-PPh2)]2 8 (X-ray). Moderate pi-pi intermolecular interactions and no evident Pt-Pt interactions are found in 1, 7b, and in 8. All of the complexes exhibit absorption bands at high energy due to the intraligand transitions (1IL pi --> pi) and absorptions at lower energy which are attributed to MLCT (5d) pi --> pi (CLambdaN) transition. Platinum complexes show strong luminescence in both solid state and frozen solutions. The influence of the coligands on the photophysics of the platinum complexes has been examined by absorption and emission spectroscopy.     

Pd.H-C Interactions. Preparation and Structure of Orthometalated Tetranuclear Complexes of Palladium(II) and Platinum(II)

The reaction of 2-(1-naphthyl)benzothiazoline with palladium(II) acetate leads to helical mononuclear and orthometalated tetranuclear products. The molecular structures of mononuclear palladium(II) [Pd(H1-nabz)(2)] (1) (H(2)1-nabz = 2-N-(1-naphthylmethylideneamino)benzenethiolate), tetranuclear palladium(II) [Pd(4)(1-nabz)(4)] (2) and tetranuclear platinum(II) [Pt(4)(1-nabz)(4)] (3) have been determined by single-crystal X-ray diffraction method. Crystal data for complex 1 are as follows: a = 14.208(3) ?, b = 18.227(4) ?, c = 14.398(8) ?; beta = 94.55(3) degrees; V = 3717.0(23) ?(3); space group = P2(1)/n, Z = 4. Crystal data for the complex 2 are as follows: a = b = 15.798(3) ?, c = 23.728(4) ?; V = 5921.7(20) ?(3); space group = I4(1)/a, Z = 16 for the Pd(1-nabz) unit. Crystal data for the complex 3 are as follows: a = b = 15.496(2) ?, c = 24.348(3) ?; V = 5846.3(20) ?(3); space group = I4(1)/a, Z = 16 for the Pt(1-nabz) unit. The mononuclear palladium(II) complex reveals short ortho-hydrogen.palladium distances of 2.66(7) and 2.48(7) ?. These short distances and (1)H NMR studies provide a M.H-C interaction which can be regarded as a three-center four-electron interaction. The molecular structures of 2 and 3 confirm the formation of unusual tetranuclear compounds featuring a rare C,N,S-tridentate ligand derived from orthometalation of pendant side arm. The structural and chemical properties of the mononuclear palladium(II) complex 1 clearly suggest that 1 is a potential intermediate in the formation of the tetranuclear complex 2 by orthometalation reactions.     

Preparation and structural characterization of ionic five-coordinate palladium(II) and platinum(II) complexes of the ligand tris[2-(diphenylphosphino)ethyl]phosphine. Insertion of SnCl(2) into M-Cl bonds (M = Pd,Pt) and hydroformylation activity of the Pt-SnCl(3) systems

The five-coordinate palladium(II) and platinum(II) complexes [M(PP(3))Cl]Cl [M = Pd (1), Pt (2)] (PP(3) = tris[2-(diphenylphosphino)ethyl]phosphine) were prepared by interaction of aqueous solutions of MCl(4)(2-) salts with PP(3) in CHCl(3). Complexes 1 and 2 undergo facile chloro substitution reactions with KCN in 1:1 and 1:2 ratios to afford complexes [M(PP(3))(CN)]Cl [M = Pt (3)] and [M(PP(3))(CN)](CN) [M = Pd (4), Pt (5)] possessing M-C bonds, both in solution and in the solid state. The reaction of 1 and 2 with SnCl(2) in CDCl(3) occurs with insertion of SnCl(2) into M-Cl bonds leading to the formation of [M(PP(3))(SnCl(3))](SnCl(3)) [M = Pd (6), M = Pt (7)]. The isolation as solids of complexes 6 and 7 by addition of SnCl(2) to the precursors requires the presence of PPh(3) which activates the cleavage of M-Cl bonds, favors the SnCl(2) insertion, and does not coordinate to M in any observable extent. Solutions of 6 in CDCl(3) undergo tin dichloride elimination in higher proportion than solutions of 7. The reaction of complexes 1 and 2 with SnPh(2)Cl(2) leads to [M(PP(3))Cl](2)[SnPh(2)Cl(4)] [M = Pd (8)]. Complexes 2, 5, 7, and 8 were shown by X-ray diffraction to contain distorted trigonal bipyramidal monocations [M(PP(3))X](+) [M = Pt, X = Cl(-) (2), X = CN(-) (5), X = SnCl(3)(-) (7); M = Pd, X = Cl(-) (8)], the central P atom of PP(3) being trans to X in axial position and the terminal P donors in the equatorial plane of the bipyramids. The "preformed" catalyst 7 showed a relatively high aldehyde selectivity compared to most of the platinum catalysts.     

Synthesis of organo-platinum(II) and -palladium(II) complexes ofN-phenyl- andN-(p-Tolyl)pyrazole

Summary When platinum(II) chloride dissolved in acetic acid containing concentrated hydrochloric acid was refluxed withN-phenylpyrazole(liphpz) andN-(p-tolyl)pyrazole (Htlpz), complexes of composition [Pt(N-C)Cl]₂ (N-C = phpz, tlpz) were obtained, in which phpz and tlpz are coordinated through nitrogen and carbon forming a five membered metallocycle. Similar palladium(II) complexes [Pd(N-C)Cl]₂ were easily prepared by the reaction of palladium(II) chloride with Hphpz and Htlpz in methanol in the presence of lithium chloride. These [M(N-C)CI]₂ complexes reacted with tri-n-butylphosphine (PBu₃) and pyridine (py) to give the adducts [M(N-C)ClL](L = PBu₃, py). Ethylenediamine(en) and acetylacetone(Hacac) gave IPd(phpz)(en)]Cl and [Pd(phpz)(acac)] respectively. These new complexes are characterized by means of¹H-n.m.r. and i.r. spectra, and probable structures are proposed.Reprints of this article are not available.     

New palladium(II) and platinum(II) complexes with the model nucleobase 1-methylcytosine: antitumor activity and interactions with DNA

Palladium and platinum complexes with the model nucleobase 1-methylcytosine (1-Mecyt) of the types [Pd(N-N)(C6F5)(1-Mecyt)]ClO4 [N-N = bis(3,5-dimethylpyrazol-1-yl)methane (bpzm), bis(pyrazol-1-yl)methane (bpzm), N,N,N',N'-tetramethylethylenediamine (tmeda), or 2,2'-bipyridine (bpy)] and [M(dmba)(L')(1-Mecyt)]ClO4 [dmba = N,C-chelating 2-(dimethylaminomethyl)phenyl; L' = PPh(3) (M = Pd or Pt), DMSO (M = Pt)] have been obtained. Palladium and platinum complexes of the types cis-[M(C6F5)2(1-Mecyt)2] (M = Pd or Pt) and cis-[Pd(L')(C6F5)(1-Mecyt)2]ClO4 (L' = PPh(3) or t-BuNC) have also been prepared. The crystal structures of [Pd(bpzm)(C6F5)(1-Mecyt)]ClO4, [Pt(dmba)(DMSO)(1-Mecyt)]ClO4, cis-[Pd(C6F5)2(1-Mecyt)2], and cis-[Pd(t-BuNC)(C6F5)(1-Mecyt)2]ClO4 have been established by X-ray diffraction. There is extensive hydrogen bonding (N-H...O, C-H...F or C-H...O) in all the compounds. There are also intermolecular pi-pi interactions between pyrimidine rings of adjacent chains in [Pd(C6F5)2(1-Mecyt)2]. DNA adduct formation of the new complexes synthesized was followed by circular dichroism and electrophoretic mobility. Atomic force microscopy images of the modifications caused by the complexes on plasmid DNA pBR322 were also obtained. Values of IC(50) were also calculated for the new complexes against the tumor cell line HL-60. At a short incubation time (24 h) almost all new complexes were more active than cisplatin.     

Synthesis, experimental and theoretical characterization of palladium(II) and platinum(II) saccharinate complexes with 2-(2-pyridyl)benzimidazole

New palladium(II) and platinum(II) complexes of saccharinate (sac) with 2-(2-pyridyl)benzimidazole (pybim) have been synthesized and characterized by elemental analysis and spectroscopic techniques. From the experimental studies, these complexes were formulated as [Pd(pybim)(sac)2] (1), and [Pt(pybim)(sac)2]·4H2O (2). The ground-state geometries of both complexes were optimized using density functional theory (DFT) methods at the B3LYP level. A bidentate pybim ligand together with two N-coordinated sac ligands form the square-planar MN4 coordination geometry around the palladium(II) and platinum(II) ions. The calculated IR and UV-vis spectral data have been correlated to the experimental results. Thermal analysis data support the molecular structures of both complexes.     

Novel luminescent hexanuclear platinum(II) alkynyl complex: molecular lego from a face-to-face dinuclear platinum(II) building block

A novel luminescent hexanuclear platinum(II) complex, [Pt(2)(mu-dppm)(2)(C[triple bond]CC(5)H(4)N)(4)[Pt(trpy)](4)](CF(3)SO(3))(8) (trpy = 2,2':6',2'-terpyridine), was successfully synthesized by using the face-to-face dinuclear platinum(II) ethynylpyridine complex [Pt(2)(mu-dppm)(2)(C[triple bond]CC(5)H(4)N)(4)] as the building block.     

Effects of the intramolecular NH...S hydrogen bond in mononuclear platinum(II) and palladium(II) complexes with 2,2'-bipyridine and benzenethiol derivatives

A series of complexes, [M(bpy)(SAr)2] (M = platinum(II) or palladium(II), bpy = 2,2'-bipyridine, SAr = 2- or 4-(acylamino)benzenethiolate, or 2-(alkylcarbamoyl)benzenethiolate), were synthesized and characterized on the basis of 1H NMR, IR, and electrochemical properties. The structures of [Pt(bpy)(S-2-Ph3CCONHC6H4)2] (1) and [Pt(bpy)(S-2-t-BuNHCOC6H4)2] (3) were determined by X-ray analysis. The complexes have intramolecular NH...S hydrogen bonds between the amide NH group and the sulfur atom. A weak NH...S hydrogen bond in these complexes and [Pd(bpy)(S-2-Ph3CCONHC6H4)2] (4) is detected from the 1H NMR spectra and the IR spectra in chloroform and in the solid state. [Pt(bpy)(S-2-Ph3CCONHC6H4)2] (1) exhibits a remarkably high-energy-shifted lowest-energy band in UV-visible spectra and has a positively shifted oxidation potential. The blue-shift of 42 nm and the positive shift of +0.24 V, as compared to those of [Pt(bpy)(SC6H5)2), are due to the effect of the NH...S hydrogen bond.     

Cyclometallated Pt(II) and Pd(II) complexes with a trithiacrown ligand

We report the synthesis and full characterization for a series of cyclometallated complexes of Pt(II) and Pd(II) incorporating the fluxional trithiacrown ligand 1,4,7-trithiacyclononane ([9]aneS3). Reaction of [M(C insertion mark N)(micro-Cl)]2 (M = Pt(II), Pd(II); C insertion mark N = 2-phenylpyridinate (ppy) or 7,8-benzoquinolinate (bzq)) with [9]aneS3 followed by metathesis with NH4PF6 yields [M(C insertion mark N)([9]aneS3)](PF6). The complexes [M(C insertion mark P)([9]aneS3)](PF6) (M = Pt(II), Pd(II); Cinsertion markP = [CH2C6H4P(o-tolyl)2-C,P]-) were synthesized from their respective [Pt(C insertion mark P)(micro-Cl)]2 or [Pd(C insertion mark P)(micro-O2CCH3)]2 (C insertion mark P) starting materials. All five new complexes have been fully characterized by multinuclear NMR, IR and UV-Vis spectroscopies in addition to elemental analysis, cyclic voltammetry, and single-crystal structural determinations. As expected, the coordinated [9]aneS3 ligand shows fluxional behavior in its NMR spectra, resulting in a single 13C NMR resonance despite the asymmetric coordination environment of the cyclometallating ligand. Electrochemical studies reveal irreversible one-electron metal-centered oxidations for all Pt(II) complexes, but unusual two-electron reversible oxidations for the Pd(II) complexes of ppy and bzq. The X-ray crystal structures of each complex indicate an axial M-S interaction formed by the endodentate conformation of the [9]aneS3 ligand. The structure of [Pd(bzq)([9]aneS3)](PF6) exhibits disorder in the [9]aneS3 conformation indicating a rare exodentate conformation as the major contributor in the solid-state structure. DFT calculations on [Pt([9]aneS3)(ppy)](PF6) and [Pd([9]aneS3)(ppy)](PF6) indicate the HOMO for both complexes is primarily dz2 in character with a significant contribution from the phenyl ring of the ppy ligand and p orbital of the axial sulfur donor. In contrast, the calculated LUMO is primarily ppy pi* in character for [Pt([9]aneS3)(ppy)](PF6), but dx2-y2 in character for [Pd([9]aneS3)(ppy)](PF6).     

Six-fold oxygen-coordinated triplet (S = 1) palladium(II) moieties templated by tris(bipyridine)ruthenium(II) ions

Tris(bipyridine)ruthenium(II) is used as a templating agent to insert palladium(II) into three-dimensional oxalate-based networks. The templated-assembly of [Ru(bpy)(3)][Pd(2)(ox)(3)] (Pd(2)) and [Ru(bpy)(3)][PdMn(ox)(3)] (PdMn) is described. The latter compound is structurally characterized by powder X-ray diffraction and X-ray absorption spectroscopy. These techniques reveal an unusual 6-fold oxygen environment around the Pd(II) atoms with two short (2.02 Angstrom) and four long (2.17 Angstrom) Pd-O distances. As stated by magnetometry, this environment is associated with a triplet ground state (S = 1) of the palladium(II) ion: when the temperature is decreased, the chiMT product shows a monotonous decrease from 5.54 cm(3) K mol(-1) at 300 K, a value which is slightly lower than the one expected for independent paramagnetic Pd(II) (S = 1, g = 2) and Mn(II) (S = 5/2, g = 2) ions. This thermal variation is due to antiferromagnetic exchange interactions between the two spin bearers. Nevertheless, no long-range magnetic order is detected down to 2 K. These results are confirmed by an analysis of the [MII(C(2)O(4))(3)](4-) (M = Ni, Pd, Pt) complex and of a [Pd(II){mu-(C(2)O(4))Mn(II)(OH(2))(4)}(3)](2+) tetranuclear model using density functional theory.     

New palladium(II) and platinum(II) complexes with 9-aminoacridine: structures, luminiscence, theoretical calculations, and antitumor activity

The new complexes [Pd(dmba)( N10-9AA)(PPh 3)]ClO 4 ( 1), [Pt(dmba)( N9-9AA)(PPh 3)]ClO 4 ( 2), [Pd(dmba)( N10-9AA)Cl] ( 3), and [Pd(C 6F 5)( N10-9AA)(PPh 3)Cl] ( 4) (9-AA = 9-aminoacridine; dmba = N,C-chelating 2-(dimethylaminomethyl)phenyl) have been prepared. The crystal structures have been established by X-ray diffraction. In complex 2, an anagostic C-H...Pt interaction is observed. All complexes are luminescent in the solid state at room temperature, showing important differences between the palladium and platinum complexes. Complex 2 shows two structured emission bands at high and low energies in the solid state, and the lifetimes are in agreement with excited states of triplet parentage. Density functional theory and time-dependent density functional theory calculations for complex 2 have been done. Values of IC 50 were also calculated for the new complexes 1- 4 against the tumor cell line HL-60. All of the new complexes were more active than cisplatin (up to 30-fold in some cases). The DNA adduct formation of the new complexes synthesized was followed by circular dichroism and electrophoretic mobility. Atomic force microscopy images of the modifications caused by the complexes on plasmid DNA pB R322 were also obtained.     

Ring-opening reactions induced by gold(I) of five- and four-coordinate palladium(II) and platinum(II) complexes containing tripodal or linear polyphosphines

The tripodal ligands NP(3)(tris[2-(diphenylphosphino)ethyl]amine) and PP(3)(tris[2-(diphenylphosphino)ethyl]phosphine), form five-coordinate [Pd(NP(3))X]X [X = Cl (1), Br (2)], [M(PP(3))X]X [M = Pd: X = Cl (4), Br (5), I (6); M = Pt, X = Cl (7), Br (8), I (9)] and four-coordinate[Pd(NP(3))I]I (3) complexes containing three fused rings around the metal. The interaction between Au(tdg)X (tdg = thiodiglycol; X = Cl, Br) or AuI and the respective ionic halo complexes 1-9 in a 1:1 stoichiometric ratio occurs via a ring-opening reaction with formation of the heterobimetallic systems PdAu(NP(3))X(3)[X = Cl (11), Br (12), I (13)], [MAu(PP(3))X(2)]X [M = Pd: X = Cl (14), Br (15), I (16); M = Pt: X = Cl (17), Br (18), I (19)]. The cations of complexes 17 and 18 were shown, by X-ray diffraction, to contain a distorted square-planar Pt(II) arrangement (Pt(P(2)P)X) where PP(3) is acting as tridentate chelating ligand and an almost linear PAuX moiety bearing the dangling phosphorus formed in the ring-opening process. PPh(3) coordinates to Au(I) and not to M(II) when added in excess to 14 and 17. Complexes 14-17 and [Pt(P(4))](BPh(4))(2) (10) (P4=linear tetraphosphine) also react with A(I), via chelate ring-openings to give MAu(2)(PP(3))X(4) [M = Pd: X = Cl (20), Br (21), I (22); M = Pt: X = Cl (23)] and [Pt(2)Au(2)(mu-Cl)(2)(mu-P(4))(2)](BPh(4))(4) (24), respectively.     

Hg(II)...Pd(II) metallophilic interactions

Reaction of bis(pentafluorophenyl)mercury (1) with the Pd(II) complexes [Pd(salophen)] (I, salophen = N,N'-disalicylidene-o-phenylenediaminate) and [Pd(N--C)(OAc)]2 (II, N--C = (2-(2-pyridyl)phenyl-C,N)) leads to the formation of the supramolecular complexes [1-(I)2] and [1-(II)2] in which the mercury synthon is sandwiched by two molecules of the palladium complex. These complexes, whose formation can be observed in solution by UV-vis spectroscopy, have been fully characterized. The short Hg-Pd distances of 3.2841(2) A in [1-(I)2] and 3.1065(8) A in [1-(II)2] indicate the presence of a Hg-Pd metallophilic interaction which, at least for [1-(II)2], is complemented by a Pd(II)-->Hg(II) donor-or component.     

Cyclometalated Complexes of Palladium(II) and Platinum(II): cis-Configured Homoleptic and Heteroleptic Compounds with Aromatic C&arcraise;N Ligands

The palladium(II) and platinum(II) bis-homoleptic complexes M(C&arcraise;N)(2), where C&arcraise;N is benzo[h]quinoline (H-bhq), 2-phenylpyridine (H-phpy), 2-(2'-benzothienyl)pyridine (H-bthpy), 2-(2'-thienyl)quinoline (H-thq), and 2-(2'-thienyl)pyridine (H-thpy), were prepared by metal exchange of the lithiated ligands C&arcraise;N with M(Et(2)S)(2)Cl(2). The palladium(II) bis-heteroleptic complexes, Pd(C&arcraise;N)(C'&arcraise;N'), were synthesized from Pd(C&arcraise;N)(2) bis-homoleptic complexes, which were converted by HCl into the dichloro-bridged compounds [Pd(C&arcraise;N)Cl](2). By addition of Et(2)S, the Pd(C&arcraise;N)(Et(2)S)Cl complexes were formed, which were allowed to react with Li(C'&arcraise;N'), yielding M(C&arcraise;N)(C'&arcraise;N') compounds. An alternative way for obtaining the bis-heteroleptic molecules is by ligand exchange, according to the equilibrium M(C&arcraise;N)(2) + M(C'&arcraise;N')(2) = 2M(C&arcraise;N)(C'&arcraise;N'). The crystal structures of Pt(bhq)(2) (1) and Pt(thq)(2) (3) present an important distortion of the square planar (SP-4) geometry toward a two-bladed helix. Bis-homoleptic and some bis-heteroleptic complexes of palladium(II) have also been synthesized. In both cases, the steric interactions between the two ligands cause again a helical distortion rather than yielding trans compounds. For cis-bis(benzo[h]quinoline)platinum(II) (1), in the crystal (monoclinic, space group P2(1)/n, a = 13.728(3) ?, b = 6.9537(15) ?, c = 19.701(5) ?, beta = 106.17(2) degrees, Z = 4, rho(calcd) = 2.028 g.cm(-)(3); diffractometer measurements, block-matrix least-squares refinement, R = 0.043, R(w) = 0.047) the average Pt-N and Pt-C distances are 2.151(6) and 1.988(7) ?, respectively. One benzo[h]quinoline ligand is significantly less planar than the other. For cis-bis[2-(2'-thienyl)quinoline]platinum(II) (3), in the crystal (trigonal, space group P3(2)21, a = b = 9.373(1) ?, c = 20.152(3) ?, Z = 3, rho(calcd) = 2.022 g.cm(-)(3); diffractometer measurements, full-matrix least-squares refinement, R = 0.010, R(w) = 0.010) the molecule has C(2) symmetry and is chiral. The Pt-N and Pt-C bond lengths are 2.156(2) and 1.984(3) ?, respectively. The quinoline moitey is not planar but bent about the fused bond by 6.8 degrees. The thiophene moiety is inclined to the best plane through the quinoline moiety by 24.4 degrees.     

Synthesis,characterization, and cytotoxicity of platinum(II)/palladium(II) complexes with 4-toluenesulfonyl-L-amino acid dianion and diimine/diamine

Eight new platinum(II)/palladium(II) complexes with 4-toluenesulfonyl-L-amino acid dianion and diimine/diamine ligands, [Pd(en)(Tsile)]·H₂O (1), [Pd(bipy)(Tsile)] (2), [Pd(bipy)(Tsthr)]·0.5H₂O (3), [Pd(phen)(Tsile)]·0.5H₂O (4), [Pd(phen)(Tsthr)]·H₂O (5), [Pd(bqu)(Tsthr)]·1.5H₂O (6), [Pt(en)(Tsser)] (7), and [Pt(en)(Tsphe)]·H₂O (8), have been synthesized and characterized by elemental analyses, ¹H NMR and mass spectrometry. The crystal structure of 7 has been determined by X-ray diffraction. Cytotoxicities were tested by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and sulforhodamine B assays. The complexes exert cytotoxicity against HL-60, Bel-7402, BGC-823, and KB cell lines with 4 having the best cytotoxicity against HL-60, Bel-7402, and BGC-823 cell lines; the compounds are less cytotoxic than cisplatin.     

Chelating or bridging Pd(II) and Pt(II) metalloligands from the functional phosphine ligand N-(diphenylphosphino)-1,3,4-thiadiazol-2-amine. New heterometallic Pd(II)/Pt(II) and Pt(II)/Au(I) complexes

The reaction of two equivalents of the functional phosphine ligand N-(diphenylphosphino)-1,3,4-thiadiazol-2-amine Ph2PNHC=NNCHS (2) with [PdCl2(NCPh)2] in the presence of NEt3 gives the neutral, P,N-chelated complex cis-[Pd(Ph2PN=CNN=CHS)2] ([Pd(2-H)2], 3b), which is analogous to the Pt(II) analogue cis-[Pt (Ph2PN=CNN=CHS)2] ([Pt(2-H)2], 3a) reported previously. These complexes function as chelating metalloligands when further coordinated to a metal through each of the CH-N atoms. In the resulting complexes, each endo-cyclic N donor of the thiadiazole rings is bonded to a different metal centre. Thus, the heterodinuclear palladium/platinum complexes cis-[Pt(Ph2PN=CNN=CHS)2PdCl2]([Pt(2-H)2·PdCl2], 4a) and cis-[Pd(Ph2PN=CNN=CHS)2PtCl2]([Pd(2-H)2·PtCl2], 4b) were obtained by reaction with [PdCl2(NCPh)2] and [PtCl2(NCPh)2], respectively. In contrast, reaction of 3a with [AuCl(tht)] occurred instead at the P-bound N atom, and afforded the platinum/digold complex cis-[Pt{Ph2PN(AuCl)=CNN=CHS}2] ([Pt(2-H)2(AuCl)2], 5). For comparison, reaction of 4a with HBF4 yielded cis-[Pt(Ph2PNH=CNN=CHS)2PdCl2](BF4)2([H24a](BF4)2, 6), in which the chelated PdCl2 moiety is retained. Complexes 3b, 4a·CH2Cl2, 4b·0.5C7H8, 5·4CHCl3 and 6 have been structurally characterized by X-ray diffraction.